MRVI – maravai lifesciences holdings, inc. - class a common stock (US:NASDAQ)
Stock Stats
News
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $4.25 price target on the stock.
Industry Veteran and Gene Therapy Manufacturing Expert, Ray Kaczmarek, Joins Nanoscope as Chief Technical and Manufacturing Officer [Yahoo! Finance]
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Form 8-K MARAVAI LIFESCIENCES For: Dec 18
Form 4 MARAVAI LIFESCIENCES For: Dec 16 Filed by: ECKERT R ANDREW
Form 4 MARAVAI LIFESCIENCES For: Dec 09 Filed by: LUCIER GREGORY T
Form 3 MARAVAI LIFESCIENCES For: Dec 05 Filed by: ECKERT R ANDREW
Form 8-K MARAVAI LIFESCIENCES For: Dec 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.